Differentiation Potential of Multipotent Progenitor Cells Derived from War-Traumatized Muscle Tissue

Nesti, Leon J.; Jackson, Wesley M.; Shanti, Rabie M.; Koehier, Steven M.; Aragon, Amber B.; Bailey, James R.; Sracic, Michael K.; Freedman, Brett A.; Giuliani, Jeffrey R.; Tuan, Rocky S.
November 2008
Journal of Bone & Joint Surgery, American Volume;Nov2008, Vol. 90-A Issue 11, p2390
Academic Journal
Background: Recent military conflicts have resulted in numerous extremity injuries requiring complex orthopaedic reconstructive procedures, which begin with a thorough débridement of all contaminated and necrotic tissue in the zone of injury. The site of injury is also the site of healing, and we propose that débrided muscle tissue contains cells with robust reparative and regenerative potential. Methods: Débrided muscle from soldiers who had sustained traumatic open extremity injuries was collected during surgical débridement procedures at Walter Reed Army Medical Center. With modifications to a previously described stem-cell-isolation protocol, mesenchymal progenitor cells were harvested from traumatized muscle, enriched, expanded in culture, and exposed to induction media for osteogenesis, adipogenesis, and chondrogenesis. Results: The isolated mesenchymal progenitor cells stained positive for cell-surface markers (CD73, CD90, CD105), which are characteristic of adult human mesenchymal stem cells. Histological identification of lineage-specific markers demonstrated the potential of these cells to differentiate into multiple mesenchymal lineages. Reverse transcriptionpolymerase chain reaction analysis confirmed multilineage mesenchymal differentiation at the gene-expression level. Conclusions: To our knowledge, the present report provides the first description of mesenchymal progenitor cell isolation from traumatized human muscle. These cells may play an integral role in tissue repair and regeneration and merit additional investigation as they could be useful in future cell-based tissue-engineering strategies. Clinical Significance: Mesenchymal progenitor cells isolated from war-traumatized tissues have the potential for applications in cell-based tissue engineering. Elucidatingthe cellular mechanisms regulating their differentiation activities may lead to the development of novel treatments for musculoskeletal trauma and pathological healing responses, such as heterotopic ossification.


Related Articles

  • Intra-brain microinjection of human mesenchymal stem cells decreases allodynia in neuropathic mice. Siniscalco, Dario; Giordano, Catia; Galderisi, Umberto; Luongo, Livio; Alessio, Nicola; Di Bernardo, Giovanni; De Novellis, Vito; Rossi, Francesco; Maione, Sabatino // Cellular & Molecular Life Sciences;Feb2010, Vol. 67 Issue 4, p655 

    Neuropathic pain is a very complex disease, involving several molecular pathways. Current available drugs are usually not acting on the several mechanisms underlying the generation and propagation of pain. We used spared nerve injury model of neuropathic pain to assess the possible use of human...

  • Preconditioning of Mesenchymal Stem Cells Increases Survival of The Cells: An In Vitro Study. Mohammadi Roushandeh, A.; Mortazavi, M.; Habibi Roudkenar, M. // Cell Journal (Yakhteh);Summer 2013 Supplement 1, Vol. 15 Issue Sup 1, p60 

    Objective: A growing number of experimental studies highlight the potential of stem cell transplantation as a novel therapeutic approach for diseases. This massive loss of stem cells post-engraftment is an impediment that lessens the effectiveness of cell transplantation therapy. Present study...

  • Drug-resistant TB defeated by stem cells. MacKenzie, Debora // New Scientist;1/18/2014, Vol. 221 Issue 2952, p12 

    The article discusses a study by Markus Maeurer of the Karolinska Institute in Stockholm, Sweden in which 16 people with drug-resistant tuberculosis (TB) in Belarus had mesenchymal stromal cells (MSCs) taken from their bodies, which were then multiplied and injected back into their blood.

  • Allogeneic haematopoietic stem cell transplantation: current status and future outlook. Aschan, Johan // British Medical Bulletin;Jan2006, Vol. 77/78 Issue 1, p23 

    Allogeneic haematopoietic stem cell transplantation (allo-SCT) is an established treatment of haematological malignancies and other immunohaematopoietic disorders. The use of unrelated donors and cord blood (CB) grafts has increased the possibilities of finding a donor, and results are...

  • Stem Cell Biology.  // Bone Marrow Transplantation;3/2/2002 Supplement, Vol. 29 Issue 5, pS65 

    Bone Marrow Transplantation (2001) 29, Suppl. 2, S65–S67. DOI: 10.1038/sj/bmt/1703461

  • Graft versus Host Disease.  // Bone Marrow Transplantation;3/2/2002 Supplement, Vol. 29 Issue 5, pS38 

    Bone Marrow Transplantation (2001) 29, Suppl. 2, S38–S40. DOI: 10.1038/sj/bmt/1703449

  • Bone marrow mesenchymal stem cell transplantation for treatment of emphysemic rats. Yumiao Zhao; Aiguo Xu; Qinfu Xu; Wei Zhao; Dandan Li; Xiang Fang; Yinlong Ren // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 4, p968 

    Objective: To study the efficacy of bone marrow mesenchymal stem cell (MSC) transplantation to treat pulmonary emphysema in rats. Methods: Sixty rats were randomly divided into control, model and transplantation groups. Each group contained 20 rats. Rat models of emphysema were established via...

  • The basic science of bone marrow aspirate concentrate in chondral injuries. Holton, James; Imam, Mohamed; Ward, Jonathan; Snow, Martyn // Orthopedic Reviews;2016, Vol. 8 Issue 3, p80 

    There has been great interest in bone marrow aspirate concentrate (BMAC) as a cost effective method in delivering mesenchymal stem cells (MSCs) to aid in the repair and regeneration of cartilage defects. Alongside MSCs, BMAC contains a range of growth factors and cytokines to support cell growth...

  • Proteomic Analysis of the Peri-Infarct Area after Human Umbilical Cord Mesenchymal Stem Cell Transplantation in Experimental Stroke. Dongsheng He; Zhuo Zhang; Jiamin Lao; Hailan Meng; Lijuan Han; Fan Chen; Dan Ye; He Zhang; Yun Xu // Aging & Disease;Oct2016, Vol. 7 Issue 5, p623 

    Among various therapeutic approaches for stroke, treatment with human umbilical cord mesenchymal stem cells (hUC-MSCs) has acquired some promising results. However, the underlying mechanisms remain unclear. We analyzed the protein expression spectrum of the cortical peri-infarction region after...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics